Clinical Trial Update: PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) [Phase 2]

View source ↗

Summary

Phase 2 PK/PD study evaluating posaconazole for empiric treatment of invasive fungal infections in neutropenic patients and for treatment of refractory invasive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Mycoses | Phase 2 | Status: COMPLETED